Chlorine in PDB 5wev: Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model

Enzymatic activity of Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model

All present enzymatic activity of Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model:
2.7.10.2;

Protein crystallography data

The structure of Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model, PDB code: 5wev was solved by M.H.Ultsch, S.Magnuson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 40.00 / 1.85
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 107.653, 69.542, 50.629, 90.00, 98.93, 90.00
R / Rfree (%) 16.6 / 19.4

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model (pdb code 5wev). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model, PDB code: 5wev:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 5wev

Go back to Chlorine Binding Sites List in 5wev
Chlorine binding site 1 out of 2 in the Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1201

b:55.5
occ:1.00
CL7 A:9ZS1201 0.0 55.5 1.0
C5 A:9ZS1201 1.7 55.0 1.0
C6 A:9ZS1201 2.7 46.7 1.0
C4 A:9ZS1201 2.7 51.8 1.0
C8 A:9ZS1201 3.1 36.0 1.0
N17 A:9ZS1201 3.3 33.6 1.0
O A:LEU855 3.5 41.2 1.0
C A:LEU855 3.8 32.5 1.0
O A:HOH1411 4.0 38.5 1.0
CB A:LEU855 4.0 24.3 1.0
CB A:VAL863 4.0 22.9 1.0
C1 A:9ZS1201 4.0 69.8 1.0
N A:GLY856 4.0 39.3 1.0
N9 A:9ZS1201 4.0 33.9 1.0
C3 A:9ZS1201 4.0 81.3 1.0
CA A:GLY856 4.1 50.8 1.0
CG2 A:VAL863 4.2 28.9 1.0
O20 A:9ZS1201 4.2 31.9 1.0
C16 A:9ZS1201 4.3 26.0 1.0
O A:GLY856 4.3 41.3 1.0
O A:HOH1359 4.5 45.5 1.0
C2 A:9ZS1201 4.5 70.0 1.0
CA A:LEU855 4.5 22.7 1.0
C A:GLY856 4.5 65.9 1.0
CG1 A:VAL863 4.6 23.9 1.0
C11 A:9ZS1201 4.7 26.8 1.0

Chlorine binding site 2 out of 2 in 5wev

Go back to Chlorine Binding Sites List in 5wev
Chlorine binding site 2 out of 2 in the Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1201

b:71.9
occ:1.00
CL24 A:9ZS1201 0.0 71.9 1.0
C3 A:9ZS1201 1.7 81.3 1.0
C2 A:9ZS1201 2.7 70.0 1.0
C4 A:9ZS1201 2.8 51.8 1.0
C8 A:9ZS1201 3.2 36.0 1.0
N9 A:9ZS1201 3.4 33.9 1.0
CD2 A:LEU983 3.6 27.5 1.0
O A:HOH1370 3.7 43.2 1.0
CG A:LEU983 3.9 27.0 1.0
CD1 A:LEU983 3.9 40.5 1.0
C1 A:9ZS1201 4.0 69.8 1.0
O A:ARG980 4.1 20.0 1.0
C5 A:9ZS1201 4.1 55.0 1.0
N17 A:9ZS1201 4.1 33.6 1.0
O A:HOH1402 4.3 48.1 1.0
C11 A:9ZS1201 4.4 26.8 1.0
CA A:ASN981 4.5 13.0 1.0
C6 A:9ZS1201 4.6 46.7 1.0
CB A:ASP994 4.7 22.6 1.0
C A:ASN981 4.7 18.8 1.0
O A:ASN981 4.8 20.3 1.0
N A:ASP994 4.8 19.4 1.0
C16 A:9ZS1201 4.8 26.0 1.0
ND2 A:ASN981 4.9 19.1 1.0

Reference:

J.Liang, A.Van Abbema, M.Balazs, K.Barrett, L.Berezhkovsky, W.S.Blair, C.Chang, D.Delarosa, J.Devoss, J.Driscoll, C.Eigenbrot, S.Goodacre, N.Ghilardi, C.Macleod, A.Johnson, P.Bir Kohli, Y.Lai, Z.Lin, P.Mantik, K.Menghrajani, H.Nguyen, I.Peng, A.Sambrone, S.Shia, J.Smith, S.Sohn, V.Tsui, M.Ultsch, K.Williams, L.C.Wu, W.Yang, B.Zhang, S.Magnuson. Identification of An Imidazopyridine Scaffold to Generate Potent and Selective TYK2 Inhibitors That Demonstrate Activity in An in Vivo Psoriasis Model. Bioorg. Med. Chem. Lett. V. 27 4370 2017.
ISSN: ESSN 1464-3405
PubMed: 28830649
DOI: 10.1016/J.BMCL.2017.08.022
Page generated: Sat Dec 12 12:36:24 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy